The Business of Biology graduate course

In the wake of the revolutions in genetics, genomics, and proteomics, scientists at the Life Sciences Institute are aiming for collaborative insights into the complexity of life at the genetic, molecular, and cellular levels.

But scientific advances, standing alone, are not enough. The question is: "How will advances in the life sciences improve our health, change our economy, and transform our society?"University President Mary Sue Coleman addresses The Business of Biology class in the Michigan League.

The Business of Biology explores that question. The course, launched in 2004, provides a "helicopter view" of the dynamic developments in the life sciences and health care and how they might change our world. Guest lecturers from the schools of Law, Medicine, and Public Health, as well as leaders from biotechnology, finance, and health care, offer insights into the effects of discoveries, advances in medical and information technology and emerging new consumerism on health and business.  The course also grapples with the complex ethical and legal issues that face individuals and society in the wake of these changes.

The Business of Biology is taught by Dr. David Canter, Executive Director of U-M's North Campus Research Complex.

The course is cross-listed in the Ross School of Business, UM Medical School, UM College of Engineering, and the UM School of Public Health (BA 518, HMP 630, PHARMACOL 620, BIOMEDE 523, ENGR 523) and is open to graduate students across the campus.